|
TMEM181 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.820500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.852600E-01 |
| Normal-vs-Stage2 |
2.017000E-01 |
| Normal-vs-Stage3 |
7.088200E-02 |
| Normal-vs-Stage4 |
5.028800E-01 |
| Stage1-vs-Stage2 |
4.454400E-01 |
| Stage1-vs-Stage3 |
2.803400E-01 |
| Stage1-vs-Stage4 |
7.589800E-01 |
| Stage2-vs-Stage3 |
8.920800E-01 |
| Stage2-vs-Stage4 |
8.357800E-01 |
| Stage3-vs-Stage4 |
7.246400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.122980E-01 |
| Normal-vs-AfricanAmerican |
1.358370E-01 |
| Normal-vs-Asian |
5.120000E-01 |
| Caucasian-vs-AfricanAmerican |
7.727800E-01 |
| Caucasian-vs-Asian |
9.657400E-01 |
| AfricanAmerican-vs-Asian |
8.852400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.051600E-01 |
| Normal-vs-Female |
1.822150E-03 |
| Male-vs-Female |
5.500800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.665390E-01 |
| Normal-vs-Extreme_Weight |
7.060800E-01 |
| Normal-vs-Obese |
4.540400E-02 |
| Normal-vs-Extreme_Obese |
8.647400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.404200E-02 |
| Normal_Weight-vs-Obese |
6.546600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.633000E-01 |
| Extreme_Weight-vs-Obese |
8.818100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.334800E-01 |
| Obese-vs-Extreme_Obese |
2.484000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.839900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.435920E-02 |
| Normal-vs-Age(61-80Yrs) |
3.812400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.341000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.482000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.316000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.922300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.563800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.123620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.332000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.860400E-01 |
| Normal-VS-Type2 PRCC |
4.229000E-01 |
| Normal-VS-KIRP CIMP |
1.065960E-02 |
| Normal-VS-Unclassified PRCC |
7.184200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.203400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.416570E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.554600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.236390E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.724830E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.353600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.972000E-01 |
| Normal-vs-N1 |
6.458200E-02 |
| Normal-vs-N2 |
3.956000E-01 |
| N0-vs-N1 |
9.314100E-02 |
| N0-vs-N2 |
5.349800E-01 |
| N1-vs-N2 |
1.543240E-01 |
|
|
